Mission Statement
At Choice PharmD, our mission is to empower healthcare providers with expert therapeutic guidance for interpreting molecular diagnostic tests. We are dedicated to advancing antimicrobial stewardship, promoting effective therapies, and improving patient outcomes by bridging molecular diagnostics with clinical expertise.
What We Do
Molecular diagnostic (PCR) testing generates detailed information related to pathogens and resistance genes. While these results are highly informative, interpretation can be complex and time-sensitive.
Choice PharmD provides pharmacist-led clinical interpretation to support providers in understanding PCR results and selecting appropriate antimicrobial therapy. Our reports are designed to complement laboratory findings by delivering clear, evidence-based treatment considerations that support patient-centered care.
See How Treatment Guidance Works
Pharmacist-Led Review
Each Choice PharmD report is reviewed by a trained clinical pharmacist.
Detected pathogens and resistance genes are carefully evaluated to determine medications that provide appropriate antimicrobial coverage. This review helps simplify complex results, including those with multiple detected pathogens or resistance markers, making treatment decisions more straightforward for providers.
Evidence-Based Therapeutic Guidance
Treatment considerations included in Choice PharmD reports are based on current clinical practice guidelines, including those published by organizations such as the Infectious Diseases Society of America (IDSA) and the Centers for Disease Control and Prevention (CDC), as well as primary medical literature.
Medication selection, dosing considerations, and duration of therapy are evaluated to support evidence-based decision-making and optimize patient outcomes.
Antimicrobial Stewardship
Antimicrobial resistance is a growing concern in healthcare. Judicious selection of antimicrobial therapy is essential to supporting patient safety and improving outcomes.
Choice PharmD pharmacists specialize in the clinical interpretation of resistance gene data and utilize the most recent published literature to guide appropriate antimicrobial use. By supporting targeted therapy, our reports help reduce unnecessary antibiotic exposure and promote responsible prescribing practices.
Understanding Antimicrobial Resistance
Antimicrobial resistance occurs when microorganisms such as bacteria, fungi, or viruses become resistant to the medications designed to eliminate them. This resistance represents a critical global health threat.
Resistance
Each year, more than 2.8 million infections in the United States are associated with antimicrobial resistance, resulting in over 35,000 deaths.
Cost
Treatments related to antimicrobial resistance contribute to more than $4.6 billion in annual healthcare costs.
Prevention
Prevention efforts, infection control measures, and improved antimicrobial use have been shown to reduce mortality associated with antimicrobial resistance.
How It Works
Choice PharmD integrates with your Laboratory Information System (LIS) to ensure fast, seamless, and accurate data transmission, enabling efficient completion of PharmD reporting.
Why Labs Partner With Choice PharmD
Choice PharmD is designed to support laboratories without disrupting existing workflows.
Our LIS integrations streamline reporting processes and allow for fast turnaround times. By delivering pharmacist-led interpretation alongside diagnostic results, labs are able to provide added clinical value while supporting providers with timely, actionable insight.
